Use/NN
of/IN
new/JJ
biologic/JJ
markers/NNS
in/IN
the/DT
ovulation/NN
induction/NN
./.

Biological/JJ
markers/NNS
of/IN
ovulation/NN
,/,
after/IN
a/DT
great/JJ
in/IN
the/DT
past/NN
,/,
have/VBP
been/VBN
fallen/VBN
into/IN
disuse/NN
for/IN
the/DT
large/JJ
diffusion/NN
of/IN
biochemical/JJ
and/CC
biophysical/JJ
ones/NNS
./.
=====
However/RB
,/,
the/DT
real/JJ
effect/NN
of/IN
hormones/NNS
involved/VBN
in/IN
ovulation/NN
is/VBZ
expressed/VBN
by/IN
biological/JJ
modifications/NNS
on/IN
target/NN
tissues/NNS
./.
=====
To/TO
explore/VB
the/DT
modifications/NNS
of/IN
not/RB
reproductive/JJ
target/NN
tissues/NNS
as/IN
ovulation/NN
markers/NNS
we/PRP
studied/VBD
the/DT
behaviour/NN
of/IN
Albuminemia/NN
,/,
Platelet/NN
Factor/NN
IV/CD
(/(
as/IN
indicator/NN
of/IN
Platelet/NN
Aggregation/NN
)/)
,/,
Type/NN
II/CD
estrogenic/JJ
receptors/NNS
in/IN
42/CD
ovulation/NN
induced/JJ
women/NNS
,/,
undergoing/VBG
our/PRP$
observation/NN
./.
=====
33/CD
of/IN
them/PRP
had/VBD
ovulation/NN
and/CC
9/CD
developed/VBD
a/DT
LUF/NN
syndrome/NN
,/,
constituting/VBG
two/CD
biological/JJ
models/NNS
of/IN
an/DT
opposite/JJ
situation/NN
for/IN
the/DT
three/CD
markers/NNS
observed/VBN
./.
=====
All/PDT
the/DT
markers/NNS
considered/VBN
were/VBD
sufficiently/RB
sensitive/JJ
,/,
but/CC
among/IN
them/PRP
,/,
Platelet/NN
Factor/NN
IV/CD
was/VBD
the/DT
most/RBS
reliable/JJ
to/TO
the/DT
hormonal/JJ
ovulatory/JJ
situation/NN
./.